20 reports

  • 4.2 Key Trends

Table ##. ##: Drug Pipeline for Peanut Allergy Epicutaneus Immunotherapy DBV technologies Viaskin Peanut* Oral immunotherapy Aimmune Therapeutics AR-## Prota PPOIT Camallergy CA-## Injectable Immunotherapy Astellas ASP-## HAL Allergy HAlMPE-## Aravax PVX-## Sublingual Immunotherapy Sanofi

  • Allergy Immunotherapy
  • Respiratory Disease
  • World
  • Merck & Co., Inc.
  • Stallergenes Greer plc

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

(France) ##.

  • Allergy Immunotherapy
  • Medical Biotechnology
  • United States
  • World
  • Market Shares

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cough And Cold
  • Therapy
  • United States
  • World
  • Product Initiative

With the same dose of Bet v ## COPs, there was a strong boost of immunogenicity with a TH## antibody response, which was a hundred times greater than with aluminum hydroxide (p##. ##).

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • Therapy
  • Anergis SA

Dupilumab (REGN-##, SAR##) is a fully human monoclonal antibody that is designed to bind to IL-##RA.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Product Initiative

Dupilumab (REGN-##, SAR##) is a fully human monoclonal antibody that is designed to bind to IL-##RA.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Product Initiative

Dupilumab (REGN-##, SAR##) is a fully human monoclonal antibody that is designed to bind to IL-##RA.

  • Allergy Immunotherapy
  • Chronic Disease
  • Cough And Cold
  • United States
  • Product Initiative

Most recently she served as the Worldwide Brand Director at Novartis Pharmaceuticals Corporation, where she was the global launch lead for Aimovig®, the first monoclonal antibody approved by the U. S.

  • Clinical Trial
  • Cough And Cold
  • HIV AIDS
  • United States
  • AcelRx Pharmaceuticals, Inc.

MONOCLONAL ANTIBODY REDUCES ALLERGEN-IGE INTERACTIONS.

  • Allergy Drug
  • Allergy Immunotherapy
  • Chronic Disease
  • Cough And Cold
  • Product Initiative

The drug candidate is a monoclonal antibody that inhibits binding of IL-## to the ST## receptor.

  • Allergy Immunotherapy
  • Cough And Cold
  • Therapy
  • United States
  • Product Initiative

Dupilumab (REGN-##, SAR##) is a fully human monoclonal antibody that is designed to bind to IL-##RA.

  • Allergy
  • Allergy Immunotherapy
  • United States
  • Product Initiative
  • Aimmune Therapeutics, Inc.

It also develops a product candidate, an anti-CD## monoclonal antibody that inhibits the production of adenosine produced by the tumor cells.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Vernalis plc

A Pilot Study Importance of IgE Antibody Fraction Size on Allergen Sensitivity of Basophils from Cat Allergic Patients on Xolair.

  • Allergy
  • Allergy Immunotherapy
  • Cough And Cold
  • Japan
  • World

Biotec Pharmacon is also evaluating European sites for clinical trials with SBG in combination with monoclonal antibodies.

  • Allergy Immunotherapy
  • Cough And Cold
  • Wound Care
  • United States
  • Product Initiative

AMG ## is a fully human monoclonal antibody.

  • Allergy Immunotherapy
  • Cough And Cold
  • United States
  • Company
  • Company Operations

The company" s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Allergy Immunotherapy
  • Cough And Cold
  • HIV AIDS
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.

AMG ## IS A FULLY HUMAN MONOCLONAL ANTIBODY.

  • Allergy Immunotherapy
  • Asthma
  • Immunotherapy
  • Therapy
  • Infinity Pharmaceuticals, Inc.

CSL-## is a monoclonal antibody act against interleukin-## receptor alpha ##.

  • Allergy Immunotherapy
  • Asthma
  • Chronic Disease
  • Cough And Cold
  • Infinity Pharmaceuticals, Inc.